Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novartis granted option for TP-10 in xeno/allotransplants; preliminary results in lung transplant

Oct. 21, 1997

Australian government awards Cortecs grant for otitis media research

Oct. 20, 1997

Advisory panel to the FDA unanimously recommends PDL's Zenapax

Oct. 20, 1997

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

BioTransplant and Novartis expand xenotransplantation collaboration

Oct. 15, 1997

Magnetic protein conjugates from Behringwerke

Oct. 15, 1997

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.